Combination of PDT and inhibitor treatment affects melanoma cells and spares keratinocytes

Free Radical Biology and Medicine

Volumn 50, Issue 2, 2011, Pages 305-312

  Kästle, Marc ^a,b   Grimm, Stefanie ^a,b   Nagel, Rena ^b   Breusing, Nicolle ^b   Grune, Tilman ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^b UNIVERSITY OF HOHENHEIM   (Germany)

Author keywords

ALA; Coculture; Free radicals; Heme oxygenase I; Melanoma; PARP; Photodynamic therapy

Indexed keywords

HEME OXYGENASE INHIBITOR; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE INHIBITOR;

ARTICLE; CANCER CELL CULTURE; CELL DIFFERENTIATION; COCULTURE; CONTROLLED STUDY; CYTOTOXICITY; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; KERATINOCYTE; MELANOMA CELL; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL;

APOPTOSIS; CELLS, CULTURED; COCULTURE TECHNIQUES; COMBINED MODALITY THERAPY; ENZYME INHIBITORS; HEME OXYGENASE-1; HUMANS; KERATINOCYTES; LIGHT; MELANOMA; PHOTOCHEMOTHERAPY; POLY(ADP-RIBOSE) POLYMERASES; REACTIVE OXYGEN SPECIES;

EID: 78651233641     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2010.11.012     Document Type: Article

References (44)

1. J. Frank, M.R. Lornejad-Schäfer, and H. Schöffel Inhibition of heme oxygenase-1 increases responsiveness of melanoma cells to ALA-based photodynamic therapy Int. J. Oncol. 31 2007 1539 1545
2. D. Nowis, M. Legat, and T. Grzela Heme oxygenase-1 protects tumor cells against photodynamic therapy-mediated cytotoxicity Oncogene 25 2006 3365 3374
3. A.W. Girotti Lipid hydroperoxide generation, turnover, and effector action in biological systems J. Lipid Res. 39 1998 1529 1542
4. T. Jung, N. Bader, and T. Grune Oxidized proteins: intracellular distribution and recognition by the proteasome Arch. Biochem. Biophys. 462 2007 231 237
5. A. Stang, E. Pukkala, and R. Sankila Time trend analysis of the skin melanoma incidence of Finland from 1953 through 2003 including 16, 414 cases Int. J. Cancer 119 2006 380 384
6. V. Madan, J.T. Lear, and R.M. Szeimies Non-melanoma skin cancer Lancet 375 2010 673 685
7. C.A. Morton, K.E. McKenna, and L.E. Rhodes Guidelines for topical photodynamic therapy: update Br. J. Dermatol. 159 2008 1245 1266
8. A. Klein, P. Babilas, and S. Karrer Photodynamic therapy in dermatology-an update 2008 J. Dtsch. Dermatol. Ges. 6 2008 839 845
9. J. Fang, T. Akaike, and H. Maeda Antiapoptotic role of heme oxygenase(HO) and the potential of HO as a target in anticancer treatment Apoptosis 9 2004 27 35
10. S. Tanaka, T. Akaike, J. Fang, T. Beppu, M. Ogawa, F. Tamura, Y. Miyamoto, and H. Maeda Antiapoptotic effect of haem oxygenase-I induced by nitric oxide in experimental solid tumour Br. J. Cancer 88 2003 902 909
11. H.E. Bryant, N. Schultz, H.D. Thomas, K.M. Parker, D. Flower, E. Lopez, S. Kyle, M. Meuth, N.J. Curtin, and T. Helleday Specific killing of BRCA2-deficient tumors with inhibitors of poly (ADP-ribose) polymerase Nature 434 2005 913 917
12. L. Vitek, and J.D. Ostrow Bilirubin chemistry and metabolism: harmful and protective aspects Curr. Pharm. Des. 15 2009 2869 2883
13. W.K. McCoubrey, T.J. Huang, and M.D. Maines Isolation and characterization of a cDNA from the rat brain that encodes hemoprotein heme oxygenase-3 Eur. J. Biochem. 247 1997 725 732
14. M. Bilban, A. Haschemi, B. Weigel, B.Y. Chin, O. Wagner, and L.E. Otterbein Heme oxygenase and carbon monoxide initiate homeostatic signalling J. Mol. Med. 86 2008 267 279
15. K. Hirai, T. Sasahira, H. Ohmori, K. Fujii, and H. Kuniyasu Inhibition of heme oxygenase-1 by zinc protoporphyrin IX reduces tumor growth of LL/2 lung cancer in C57BL mice Int. J. Cancer 120 2006 500 505
16. M.J. O'Connor, N.M.B. Martin, and G.C.M. Smith Targeted cancer therapies based on the inhibition of DNA strand break repair Oncogene 26 2007 7816 7824
17. S.H. Huang, M. Xiong, X.P. Chen, Z.Y. Xiao, Y.F. Zhao, and Z.Y. Huang PJ-34, an inhibitor of PARP-1, suppresses cell growth and enhances the suppressive effects of cisplatin in liver cancer cells Oncol. Rep. 20 2008 567 572
18. C.R. Calabrese, M.A. Batey, and H.D. Thomas Identification of potent nontoxic poly(ADP-ribose polymerase-1 inhibitors: chemopotentiation and pharmacological studies Clin. Cancer Res. 9 2003 2711 2718
19. Z. Herceg, and Z.Q. Wang Functions of (ADP-ribose)polymerase (PARP) in DNA repair, genomic integrity and cell death Mutat. Res. 477 2001 97 110
20. D. D'Amours, S. Desnoyers, I. D'Silva, and G.G. Poirier Poly(ADP-ribosyl)ation reaction in the regulation of nuclear functions Biochem. J. 342 1999 249 268
21. A.I. Scovassi, C. Mariani, M. Negroni, C. Negri, and U. Bertazzoni ADP-ribosylation of nonhistone proteins in HeLa cells: modification of DNA topoisomerase II Exp. Cell Res. 206 1993 177 181
22. J. Wesierska-Gadek, A. Bugajska-Schretter, and C. Cerni ADP-ribosylation of p53 tumor suppressor protein: mutant but not wild-type p53 is modified J. Cell. Biochem. 62 1996 90 101
23. P. Adamietz, and A. Rudolph ADP-ribosylation of nuclear proteins in vivo J. Biol. Chem. 259 1984 6841 6846
24. K. Yoshihara, A. Itaya, and Y. Tanaka Inhibition of DNA polymerase α, DNA polymerase β, terminal deoxynucleotidyl transferase, and DNA ligase II by poly(ADP-ribosyl)ation reaction in vitro Biochem. Biophys. Res. Commun. 128 1985 61 67
25. M. Shear The aggressive nature of the odontogenic keratocyst: is it a benign cystic neoplasm? Part 3. Immunocytochemistry of cytokeratin and other epithelial cell markers Oral Oncol. 38 2002 407 415
26. G.J. Adema, A.J. Boer, and van't Hullenaar Melanocyte lineage-specific antigens recognized by monoclonal antibodies NKI-beteb, HMB-50, and HMB-45 are encoded by a single cDNA Am. J. Pathol. 143 1993 1579 1585
27. C. Vennegoor, P. Hageman, and H. van Nouhuijs A monoclonal antibody specific for cells of the melanocyte lineage Am. J. Pathol. 130 1988 179 192
28. J. Fuchs, S. Weber, and R. Kaufmann Genotoxic potential of porphyrin type photosensitizers with particular emphasis on 5-aminolevulinic acid: implications for clinical photodynamic therapy Free Radic. Biol. Med. 28 2000 537 548
29. H. Kolarova, R. Bajgar, K. Tomankova, P. Nevrelova, and J. Mosinger Comparison of sensitizers by detecting reactive oxygen species after photodynamic reaction in vitro Toxicol. in Vitro 21 2007 1287 1291
30. H. Kolarova, P. Nevrelova, R. Bajgar, D. Jirova, K. Kejlova, and M. Strnad In vitro photodynamic therapy on melanoma cell lines with phthalocyanine Toxicol. in Vitro 21 2007 249 253 (Pubitemid 46205090)
31. L. Leibovici, N. Schoenfeld, and H.A. Yehoshua Activity of porphobilinogen deaminase in peripheral blood mononuclear cells of patients with metastatic cancer Cancer 62 1988 2297 2300
32. H.A. Dailey, and A. Smith Differential interaction of porphyrins used in photoradiation therapy with ferrochelatase Biochem. J. 223 1984 441 445 (Pubitemid 14023016)
33. P. Mroz, Y.Y. Huang, and A. Szokalska Stable synthetic bacteriochlorins overcome the resistance of melanoma to photodynamic therapy FASEB J. 24 2010 3160 3170
34. Q. Peng, T. Warloe, and K. Berg 5-Aminolevulinic acid-based photodynamic therapy Cancer 12 1997 2282 2308
35. A. Casas, C. Perotti, and B. Ortel Tumor cell lines resistant to ALA-mediated photodynamic therapy and possible tools to target surviving cells Int. J. Oncol. 29 2006 397 405
36. N. Breusing, S. Grimm, D. Mvondo, A. Flaccus, H.K. Biesalski, and T. Grune Light-induced cytotoxicity after aminolevulinic acid treatment is mediated by heme J. Photochem. Photobiol. B 99 2010 36 43
37. J. Balla, K.N. Nath, G. Balla, M.B. Juckett, H.S. Jacob, and G.M. Vercelotti Endothelial cell heme oxygenase and ferritin induction in rat lung by hemoglobin in vivo Am. J. Physiol. 268 1995 L321 L327
38. A. Jozkowitcz, H. Was, and J. Dulak Heme oxygenase-1 in tumors: is it a false friend? Antioxid. Redox Signaling 9 2007 2099 2118
39. S.J. Veuger, N.J. Curtin, C.J. Richardson, G.C.M. Smith, and B.W. Durkacz Radiosensitization and DNA repair inhibition by the combined use of novel inhibitors of DNA-dependent protein kinase and poly/ADP-ribose)polymerase-1 Cancer Res. 63 2003 6008 6015
40. H. Toshimitsu, Y. Yoshimoto, and C.K. Augustine Inhibition of poly(ADP-ribose) polymerase enhances the effect of chemotherapy in an animal model of regional therapy for the treatment of advanced extremity malignant melanoma Ann. Surg. Oncol. 17 2010 2247 2254
41. M. Korbelik, J. Sun, and P.W. Payne Activation of poly(adenosine diphosphate-ribose) polymerase in mouse tumors treated by photodynamic therapy Photochem. Photobiol. 78 2003 400 406
42. P. Boukamp, R.T. Petrussevska, D. Breitkreuz, J. Hornung, A. Makham, and N.E. Fusenig Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line J. Cell Biol. 106 1988 761 771
43. C. Garbe, P. Terheyden, and U. Keilholz Treatment of melanoma Dtsch. Artztbl. Int. 105 2008 845 851
44. C. Erickson, and S.J. Miller Treatment options in melanoma in situ: topical and radiation therapy, excision and Mohs surgery Int. J. Dermatol. 49 2010 482 491